Safranal-Standardized Saffron Extract Improves Metabolic, Cognitive, and Anxiolytic Outcomes in Aged Mice via Hypothalamic–Amygdalar Peptide Modulation
Nutrients · 2026
DOI: 10.3390/nu18020291 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2026. Verfasst von Juan A Navarro und 10 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Neuropsicofarmacología, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, …. Hauptthemen laut MEDLINE: Crocus, Plant Extracts, Amygdala, Anti-Anxiety Agents. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III (ISCIII) and European Union, Ministerio de Ciencia e Innovación - Agencia Estatal de Investigación, Consejería de Salud y Consumo - Junta de Andalucía.
Abstract (Originalsprache)
Background
Population aging increases susceptibility to cognitive decline, anxiety, and metabolic dysregulation, yet safe and effective interventions remain limited. Saffron (Crocus sativus L.) has been traditionally used to enhance mood and cognition, and its main metabolites, crocins and safranal, exert neuroprotective, anxiolytic, and metabolic effects. However, variability in extract composition and frequent adulteration hinder reproducibility.
Objectives
To clarify the efficacy of genuine saffron preparations in aging, we investigated a saffron extract standardized for safranal and crocin content (SSE).
Methods
Safranal bioavailability was first characterized in rats, followed by an evaluation of behavioral, neuroendocrine, and metabolic outcomes after 35 days of oral SSE administration (25 or 200 mg/kg/day) in 25-month-old male C57BL/6 mice. Behavioral performance was assessed using open field and novel object recognition tests, while molecular analyses targeted neuropeptides in the hypothalamus and amygdala, hippocampal plasticity markers, cortical inflammatory proteins, and hepatic lipid metabolism genes.
Results
SSE administration induced a rapid but transient increase in the plasma’s safranal, confirming its bioavailability. In aged mice, the low dose prevented age-related weight loss and modulated hepatic lipid metabolism, whereas the high dose reduced anxiety-like behavior and improved recognition memory. The anxiolytic effects are consistent with elevated hypothalamic Npy, an anxiolytic peptide, reduced amygdalar Crh, a key mediator of stress and anxiety, and decreased hypothalamic Hcrt, an arousal modulator. The improvement in memory is associated with modulation of the cortical and hippocampal inflammatory and endocannabinoid proteins involved in neural plasticity.
Conclusions
These findings highlight content-standardized saffron extracts as a promising multi-target nutraceuticals for healthy aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Grupo de Neuropsicofarmacología, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain.
- Unidad Clínica de Neurología, Hospital Regional Universitario, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain.
- Unidad Clínica de Salud Mental, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain.
- Departamento de Bioquímica, Biología Molecular e Inmunología, Facultad de Medicina, Universidad de Málaga, 29010 Málaga, Spain.
- Andalusian Network for Clinical and Translational Research in Neurology [NEURO-RECA], 29001 Málaga, Spain.
- Euronutra S.L., Calle Johannes Kepler, 3, 29590 Málaga, Spain.
ORCID-Profile: Juan A Navarro, Elena Baixeras, Juan Decara, Pedro J Serrano-Castro, Carlos Sanjuan, Antonia Serrano, Fernando Rodríguez de Fonseca
Förderung
- Instituto de Salud Carlos III (ISCIII) and European Union
- Ministerio de Ciencia e Innovación - Agencia Estatal de Investigación
- Consejería de Salud y Consumo - Junta de Andalucía
- Consejería de Universidad, Investigación e Innovación - Junta de Andalucía
- Instituto de Salud Carlos III
- Ministerio de Ciencia e Innovación—Agencia Estatal de Investigación
- Consejería de Salud y Consumo -Junta de Andalucía
- Partnership Fostering a European Research Area for Health
Zitieren
APA
Navarro, J. A., Gavito, A., Rivas, S., Rodríguez-Martín, A., Baixeras, E., Decara, J., Serrano-Castro, P. J., Alfonso, Y., Sanjuan, C., Serrano, A., & Rodríguez de Fonseca, F. (2026). Safranal-Standardized Saffron Extract Improves Metabolic, Cognitive, and Anxiolytic Outcomes in Aged Mice via Hypothalamic–Amygdalar Peptide Modulation. Nutrients. https://doi.org/10.3390/nu18020291
Vancouver
Navarro JA, Gavito A, Rivas S, Rodríguez-Martín A, Baixeras E, Decara J, et al. Safranal-Standardized Saffron Extract Improves Metabolic, Cognitive, and Anxiolytic Outcomes in Aged Mice via Hypothalamic–Amygdalar Peptide Modulation. Nutrients. 2026. doi:10.3390/nu18020291
BibTeX
@article{Navarro2026,
author = {Navarro, Juan A and Gavito, Ana and Rivas, Sonia and Rodríguez-Martín, Alonso and Baixeras, Elena and Decara, Juan and Serrano-Castro, Pedro J and Alfonso, Yolanda and Sanjuan, Carlos and Serrano, Antonia and Rodríguez de Fonseca, Fernando},
title = {Safranal-Standardized Saffron Extract Improves Metabolic, Cognitive, and Anxiolytic Outcomes in Aged Mice via Hypothalamic–Amygdalar Peptide Modulation},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18020291}
}
EUVIMED